Featured Posts
Blog
This week in health care policy: September 28 – October 2, 2026
Drug pricing CMS finalizes GLOBE pilot. On September 30, CMS finalized the Global Benchmark for Efficient Drug Pricing model, a…
National Review
Prescription Drugs Save Lives at a (Mostly) Reasonable Cost
Prescription drugs are an extraordinary lifesaving and life-enhancing technology, so integrated into our daily lives that, nowadays, we perhaps take them for granted. Headlines and…
News Release
FDA deserves credit for approval pancreatic cancer drug
The FDA on August 26 approved a new breakthrough drug to treat pancreatic cancer. CEI Senior Fellow and Economist Jeremy Nighohossian praised…
Search Posts
Op-Eds
The Poor Suffer as UN Wages War on Science
UN Secretary-General Kofi Annan recently declared that the global pursuit of scientific endeavors is marked by inequality. Noting that developing countries invest much less…
Op-Eds
CEI Does Cancún
From September 10 through September 14, the World Trade Organization will hold its fifth Ministerial meeting in Cancún, Mexico. The Competitive Enterprise Institute will be…
Op-Eds
‘I’m Mo Green!’
CANCUN, Mexico — “I’m Mo Green!” bellowed the casino owner, suggesting that his uninvited but insistent suitor Michael Corleone appreciate their relative stations in the…
Op-Eds
Precaution without Principle
The European Parliament voted earlier this summer to change the way it regulates gene-splicing, or genetic modification (GM) technology, possibly opening the way…
Products
September Edition of Monthly Planet
Full Document Available in PDF Articles in this edition: “The…
Op-Eds
EU Over-REACH
The latest mutation of the Precautionary Principle–which would heavily regulate, if not prohibit, any product, technology or activity that is in any way incomplete–is…